Previous 10 | Next 10 |
Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of Mobidiag Oy, an innovator in near-patient, acute care molecular diagnostic testing, for an enterprise value of approximately $808 million. “Closing the acqui...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IHF. A list of cheap stocks. For further details see: IHF: Healthcare Dashboard For June
Glenview Capital Management’s 13F portfolio value increased from $4.36B to $5.90B this quarter. The number of positions increased from 54 to 63. They increased AmerisourceBergen, Facebook, Alphabet, and Baxter International while reducing Laboratory Corp. and dropping Expedia G...
The end of the pandemic looks to finally be in sight as the number of new cases of COVID-19 in the U.S. has fallen to lows not seen in over a year. And the numbers will likely continue to fall as more people receive vaccines. While some companies will do better now as things return to norma...
New Coverage Further Validates Laparoscopic Radiofrequency Ablation (Lap-RFA) as a Standard of Care for Uterine Fibroids Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that Cigna, one of the largest global health insurance service com...
Abbott Laboratories ([[ABT]] +1.1%) is trading higher today after its downward revision to the 2021 guidance dragged the COVID-19 test makers across the board yesterday amid fears of slowing demand for tests as vaccinations continue.Highlighting its impact on companies reliant on PC...
My Roth IRA portfolio of 29 CEFs and 30 REITs for income, and 119 stocks for swing trading under-performing S&P 500 stocks, continues to realize profits. In May, I closed 8 stock trades for a net gain, including dividends, of 38.79% (median) or 34.65% (cost-weighted), for an avera...
Cedar Creek Partners is a hedge fund. The fund applies the typical bottom-up concentrated value approach of looking for a discount to intrinsic value to the neglected ares of the market, micro and nano caps. The S&P 500 rose 6.3%, and the NASDAQ was the weak performer, posting a 2...
#Investors in Hologic (NASDAQ: HOLX) like to make good #decisions, that means they like to #buyandsell at the right times, and to do that the best tools involve charts, pivot points, and the technical data. Below, we have provided a snapshot for HOLX that reveals this...
--Hologic’s Acessa® Procedure Now Part of the Procedural Intervention Standard of Care for Uterine Fibroids-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that the American College of Obstetricians and Gynecologists (ACO...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...